标题:Recent development of lipoxygenase inhibitors as anti-inflammatory agents
作者:Hu, Chaoyu; Ma, Shutao
作者机构:[Hu, Chaoyu; Ma, Shutao] Shandong Univ, Dept Med Chem, Key Lab Chem Biol, Minist Educ,Sch Pharmaceut Sci, 44 West Culture Rd, Jinan 250012, Shandong, 更多
通讯作者:Ma, ST
通讯作者地址:[Ma, ST]Shandong Univ, Dept Med Chem, Key Lab Chem Biol, Minist Educ,Sch Pharmaceut Sci, 44 West Culture Rd, Jinan 250012, Shandong, Peoples R China.
来源:MEDCHEMCOMM
出版年:2018
卷:9
期:2
页码:212-225
DOI:10.1039/c7md00390k
摘要:Inflammation is favorable in most cases, because it is a kind of body defensive response to external stimuli; sometimes, inflammation is also harmful, such as attacks on the body's own tissues. It could be that inflammation is a unified process of injury and resistance to injury. Inflammation brings extreme pain to patients, showing symptoms of rubor, swelling, fever, pain and dysfunction. As the specific mechanism is not clear yet, the current anti-inflammatory agents are given priority for relieving suffering of patients. Thus it is emergent to find new anti-inflammatory agents with rapid effect. Lipoxygenase (LOX) is a kind of rate-limiting enzyme in the process of arachidonic acid metabolism into leukotriene (LT) which mediates the occurrence of inflammation. The inhibition of LOX can reduce LT, thereby producing an anti-inflammatory effect. In this review, the LOX inhibitors reported in recent years are summarized, and, in particular, their activities, structure-activity relationships and molecular docking studies are emphasized, which will provide new ideas to design novel LOX inhibitors.
收录类别:SCOPUS;SCIE
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042684539&doi=10.1039%2fc7md00390k&partnerID=40&md5=cfe2acd33846ffd8ade1fe78da71a71e
TOP